The Astra Zeneca vaccine, which was developed in collaboration with researchers at the University of Oxford, will be given in two doses between four to twelve weeks. The idea is that vaccinations will start early next year.
One of the advantages of the Astra Zeneca vaccine is that it can be handled at normal refrigerator temperatures.
to me TT It is an emergency approval from MHRA. This means that the vaccine will continue to be studied.
It is expected that the European Union approval of the Astra Zeneca vaccine will take a little longer.
The EU plan remains unchanged: approval will come at the earliest in late January, most likely early February. As I understand it, the European Medicines Agency (EMA) is awaiting the results of the clinical study underway in the US. According to the company, this should be ready in a few weeks, says Swedish Vaccine Coordinator Richard Bergstrom. TT.
In Sweden, vaccinations against covid-19 began on December 27 with the Pfizer / Biontech vaccine, which received conditional approval from the European Commission on December 21.
This week, about 80,000 new doses of the vaccine are expected to be delivered to the regions of the country. At the same time reports today’s news Several areas in Sweden have been able to administer more doses than planned. This is because the vials distributed by Pfizer have been shown to contain more vaccines than the five recommended doses.
We used the extra vaccine that was in the bottles, so we could give about 215 people a vaccine instead of the 200 people we were relying on, says Anders Nordmark, Vaccine Coordinator in Värmland, to Dagens Nyheter.
He notes, however, that great care must be taken in formulating the first five doses so that the bottles are sufficient for a sixth dose. If the sixth dose is too small, then it is not used.
Discussions are currently underway between Pfizer / Biontech and the European Medicines Agency (EMA) to update the summary of product characteristics regarding number of doses per bottle.
More vaccine doses are on the way to Sweden
The first results on the effect of Astra Zeneca Coronary Vaccine have been published